News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
CCIAM FUTURE EN (00145.HK) Reappoints Executive Director
CCIAM FUTURE EN (00145.HK) announced that as the term of office of Executive Director Su Dawen expired on April 30 this year, Mr. Su has been reappointed as an Executive Director. ...
Reset
Send
The window will close in 5 seconds
CCIAM FUTURE EN (00145.HK) Reappoints Executive Director
Close
Recommend
2
Positive
1
Negative
2
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

CCIAM FUTURE EN (00145.HK)  -0.003 (-1.546%)   announced that as the term of office of Executive Director Su Dawen expired on April 30 this year, Mr. Su has been reappointed as an Executive Director. Mr. Sus new term will run from May 1, 2026 to April 30, 2027, subject to re-election and retirement in accordance with the Companys articles of association. His directors fee is HKD50,000 per month, which was determined by the Board with reference to his duties, experience and responsibilities in the Company as well as prevailing market conditions. (ec/w)(HK stocks quote is delayed for at least 15 mins.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.
Reappointment of Executive Director



AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.